SEC Filing Details
Document Details
Form
Filing Date
Feb 06, 2020
Document Date
Feb 04, 2020
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Agios Pharmaceuticals, Inc.
Issuer
AGIOS PHARMACEUTICALS, INC.
Filer
Bowden Christopher
